Resource Center
Resource Center
Statement from CHAI Interim Co-CEOs Joy Phumaphi and Ann Veneman and Board Chair Alan Schwartz on the passing of Dr. Paul Farmer
Read more
CHAI has developed a database to help suppliers better navigate market opportunities for human papillomavirus, pneumococcal conjugate, rotavirus, and inactivated polio vaccines in middle-income countries (MICs).
Read more
CHAI, with support from UBS Optimus Foundation (UBSOF) and The American Cancer Society (ACS), has been working with the Cameroonian National Cancer Program to improve access to quality pediatric care in the country.
Read more
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI.
Read more
Cervical cancer is one of the most preventable types of cancer but continues to be a leading cause of disease and death for women in low- and middle-income countries (LMICs). More than 300,000 women die of cervical cancer each year, with more than 90 percent of deaths occurring in LMICs. Human papillomavirus (HPV) vaccination and...
Read more
In 2021, CHAI and partners worked together with the Ministry of Health, Indonesia, to roll out pneumococcal conjugate vaccines to the four provinces of NTB, Babel, East Java, and West Java.
Read more
CHAI together with partners has developed a public resource that provides manufacturers, distributors, donors, and other stakeholders with short- and longer-term forecasts of malaria commodity needs and demand to prepare for disruptions in the market.
Read more
CHAI supported the government of Zimbabwe to conduct a study published in the AIDS journal to examine whether the use of point-of-care (POC) VL testing at health facilities during pregnancy improved HIV viral suppression at delivery.
Read more
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI.
Read more
CHAI in partnership with Cambodia’s Preventable Medicine Department and the Provincial Health Department of Takeo and Kampong Chhnang Provinces, designed and implemented a pilot program to provide adults over 40 with diabetes and hypertension screening while they received their COVID-19 vaccinations.
Read more